Pacific Shuanglin Bio-pharmacy Co., LTD Statistics

Total Valuation

Pacific Shuanglin Bio-pharmacy Co., LTD has a market cap or net worth of CNY 16.38 billion. The enterprise value is 15.21 billion.

Market Cap	16.38B
Enterprise Value	15.21B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jun 28, 2024

Share Statistics

Pacific Shuanglin Bio-pharmacy Co., LTD has 731.07 million shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	n/a
Shares Outstanding	731.07M
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	4.42%
Owned by Institutions (%)	30.21%
Float	263.02M

Valuation Ratios

The trailing PE ratio is 19.73 and the forward PE ratio is 18.60.

PE Ratio	19.73
Forward PE	18.60
PS Ratio	5.75
PB Ratio	2.09
P/TBV Ratio	n/a
P/FCF Ratio	52.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.37, with an EV/FCF ratio of 48.86.

EV / Earnings	18.36
EV / Sales	5.35
EV / EBITDA	14.37
EV / EBIT	16.84
EV / FCF	48.86

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.08.

Current Ratio	4.06
Quick Ratio	2.70
Debt / Equity	0.08
Debt / EBITDA	0.56
Debt / FCF	1.91
Interest Coverage	81.29

Financial Efficiency

Return on equity (ROE) is 11.08% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	11.08%
Return on Assets (ROA)	6.53%
Return on Capital (ROIC)	7.04%
Revenue Per Employee	1.17M
Profits Per Employee	341,570
Employee Count	2,426
Asset Turnover	0.33
Inventory Turnover	1.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.50% in the last 52 weeks. The beta is 0.45, so Pacific Shuanglin Bio-pharmacy Co., LTD's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-5.50%
50-Day Moving Average	22.98
200-Day Moving Average	26.01
Relative Strength Index (RSI)	44.87
Average Volume (20 Days)	11,193,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pacific Shuanglin Bio-pharmacy Co., LTD had revenue of CNY 2.84 billion and earned 828.65 million in profits. Earnings per share was 1.14.

Revenue	2.84B
Gross Profit	1.47B
Operating Income	903.48M
Pretax Income	937.59M
Net Income	828.65M
EBITDA	1.05B
EBIT	903.48M
Earnings Per Share (EPS)	1.14

Full Income Statement

Balance Sheet

The company has 1.75 billion in cash and 596.18 million in debt, giving a net cash position of 1.16 billion or 1.58 per share.

Cash & Cash Equivalents	1.75B
Total Debt	596.18M
Net Cash	1.16B
Net Cash Per Share	1.58
Equity (Book Value)	7.82B
Book Value Per Share	10.71
Working Capital	2.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 680.81 million and capital expenditures -369.47 million, giving a free cash flow of 311.34 million.

Operating Cash Flow	680.81M
Capital Expenditures	-369.47M
Free Cash Flow	311.34M
FCF Per Share	0.43

Full Cash Flow Statement

Margins

Gross margin is 51.53%, with operating and profit margins of 31.77% and 29.13%.

Gross Margin	51.53%
Operating Margin	31.77%
Pretax Margin	32.97%
Profit Margin	29.13%
EBITDA Margin	36.93%
EBIT Margin	31.77%
FCF Margin	10.95%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.88%.

Dividend Per Share	0.20
Dividend Yield	0.88%
Dividend Growth (YoY)	149.23%
Years of Dividend Growth	1
Payout Ratio	19.11%
Buyback Yield	0.20%
Shareholder Yield	1.09%
Earnings Yield	5.07%
FCF Yield	1.90%

Dividend Details

Stock Splits

The last stock split was on July 27, 2020. It was a forward split with a ratio of 1.7947843567.

Last Split Date	Jul 27, 2020
Split Type	Forward
Split Ratio	1.7947843567

Scores

Pacific Shuanglin Bio-pharmacy Co., LTD has an Altman Z-Score of 10.74.

Altman Z-Score	10.74
Piotroski F-Score	n/a